<DOC>
	<DOCNO>NCT01268943</DOCNO>
	<brief_summary>The purpose study seek proper dose capecitabine post-operative concurrent chemotherapy stage II/III elderly rectal cancer patient receive radical surgery , evaluate toleration modality patient .</brief_summary>
	<brief_title>Study Postoperative Concurrent Chemo-radiation With Capecitabine Elderly Rectal Cancer Patients</brief_title>
	<detailed_description>For `` young '' locally advance ( stage II/III ) rectal cancer patient ( usually mean patient less 70 ) , suggest radical surgery , patient receive concurrent chemo-radiation . Capecitabine widely use chemotherapy medicine condition . Based experience , investigator think modality also tolerate patient 70 , increase local control rate prove young one . As first step test hypothesis , design phase I study seek proper dose capecitabine , widely use oral chemotherapy medicine , postoperative concurrent chemo-radiation stage II/III rectal cancer patient 70 , evaluate safety modality group patient .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>rectal adenocarcinoma , pathological stage II/III ( T34 N+ , UICC 2002 ) , radical surgery receive . interval surgery enrollment less two week 3 month . KPS status le 70 ; life expectancy le 6 month . without lifethreatening complication , severe hypertension , coronary heart disease , cerebral vascular disease , uncontrolled diabetes , etc . without severe drug allergy history . hemoglobin &gt; = 100g/L , white blood cell &gt; = 3.5*10E9/L , neutrophil &gt; = 1.5*10E9/L , platelet &gt; = 100*10E9/L . Creatin &lt; = 1.5* ULN ( upper limit normal ) , Total bilirubin &lt; = 2.5 ULN , AST AST &lt; = 2.5* ULN , AKP &lt; = 2.5*ULN receive chemotherapy six month enrollment . previously pelvic irradiation history inform consent sign cancer history , except curable nonmelanoma skin cancer cervix insitu carcinoma allergy history thymidine phosphorylase previous pelvic irradiation history receive adjuvant chemotherapy six month enrollment active infection exist severe complication , acute myocardial infarction 6 month , uncontrolled diabetes ( Plasma glucose concentration time day≥11.1mmol/L） , severe cardiac arrhythmia， etc . life expectancy le 6 month estimate finish treatment attend clinical trial four week enrollment receive anticancer treatment currently condition regard illegal censor full reason . example , condition may conflict protocol .</criteria>
	<gender>All</gender>
	<minimum_age>71 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>rectal neoplasm</keyword>
	<keyword>age</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>drug therapy</keyword>
	<keyword>dose-escalation</keyword>
	<keyword>capecitabine</keyword>
</DOC>